FDA Inspection 972378 — Neo Vision Co Ltd

Neo Vision Co Ltd — FEI 3009674807

The FDA completed an inspection of Neo Vision Co Ltd on May 12, 2016 in Yongin. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
May 12, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Yongin (Korea (the Republic of))

Citations

IDCFRDescription
237121 CFR 820.30(a)Design control - no procedures
316021 CFR 820.184Lack of or inadequate DHR procedures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures
53721 CFR 820.70(a)Production processes
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.